• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国双膦酸盐治疗后非典型股骨骨折的发生率。

Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea.

机构信息

Department of Orthopedic Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

出版信息

J Korean Med Sci. 2018 Jan 29;33(5):e38. doi: 10.3346/jkms.2018.33.e38.

DOI:10.3346/jkms.2018.33.e38
PMID:29349947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5773851/
Abstract

BACKGROUND

Atypical femoral fracture (AFF) has been high-lightened, because it was associated with the long-term use of bisphosphonate. Comparing western countries, the incidence rate of AFF was unclear in East Asian patients. Our purposes were to estimate the incidence rate of radiologically defined AFF in Korea, and to determine the association between occurrence of AFF and long-term use of bisphosphonate.

METHODS

We conducted a hospital-based, retrospective cohort study in patients aged ≥ 45 years, who took bisphosphonate. The occurrence of AFF was estimated by using incidence rate, and the age-adjusted incidence rate to U.S. 2010 Census data. The association between occurrence of AFF and the duration of bisphosphonate use was examined. The cumulative probability of AFF was plotted per each duration of bisphosphonate use.

RESULTS

Among 10,338 individuals who took bisphosphonate, 13 patients with AFF following use of bisphosphonate were identified. The incidence rate was 85.9/100,000 person-years (95% confidence interval [CI], 50.2-146.9), and age-adjusted incidence rate was 72.7/100,000 person-years (95% CI, 29.1-175.8). In Poisson regression analysis, higher body mass index (BMI) was associated with an increased risk of AFF (relative risk, 1.2; 95% CI, 1.004-1.359). The cumulative probability of AFF increased abruptly when the duration of bisphosphonate use was 4 years or more.

CONCLUSION

Among Korean patients, the incidence rate of AFF was on a par with those of western countries, and this can provide basic information to conduct further studies by evaluating risk and benefit of continuing bisphosphonate.

摘要

背景

非典型股骨骨折(AFF)已引起重视,因为它与长期使用双膦酸盐有关。与西方国家相比,东亚患者的 AFF 发病率尚不清楚。我们的目的是评估韩国放射学定义的 AFF 的发病率,并确定 AFF 的发生与长期使用双膦酸盐之间的关系。

方法

我们对≥45 岁、服用双膦酸盐的患者进行了一项基于医院的回顾性队列研究。使用发病率和年龄调整后的发病率来评估 AFF 的发生率,以与美国 2010 年人口普查数据进行比较。检查 AFF 的发生与双膦酸盐使用时间之间的关系。根据双膦酸盐使用时间绘制 AFF 的累积概率图。

结果

在 10338 名服用双膦酸盐的患者中,发现了 13 例 AFF 患者。发病率为 85.9/100,000 人年(95%置信区间 [CI],50.2-146.9),年龄调整后的发病率为 72.7/100,000 人年(95%CI,29.1-175.8)。在泊松回归分析中,较高的体重指数(BMI)与 AFF 的风险增加相关(相对风险,1.2;95%CI,1.004-1.359)。当双膦酸盐使用时间达到 4 年或以上时,AFF 的累积概率急剧增加。

结论

在韩国患者中,AFF 的发病率与西方国家相当,这可以提供基本信息,通过评估继续使用双膦酸盐的风险和获益来进一步开展研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ee/5773851/c4e1c687c76d/jkms-33-e38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ee/5773851/9fc91367bbf5/jkms-33-e38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ee/5773851/c4e1c687c76d/jkms-33-e38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ee/5773851/9fc91367bbf5/jkms-33-e38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ee/5773851/c4e1c687c76d/jkms-33-e38-g002.jpg

相似文献

1
Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea.韩国双膦酸盐治疗后非典型股骨骨折的发生率。
J Korean Med Sci. 2018 Jan 29;33(5):e38. doi: 10.3346/jkms.2018.33.e38.
2
Trends in the incidence of atypical femoral fractures and bisphosphonate therapy.非典型股骨骨折的发病率趋势与双膦酸盐治疗
J Orthop Surg (Hong Kong). 2016 Apr;24(1):36-40. doi: 10.1177/230949901602400110.
3
The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.接受口服双膦酸盐治疗的老年女性中种族/民族与非典型股骨骨折风险的关联。
Bone. 2016 Apr;85:142-7. doi: 10.1016/j.bone.2016.01.002. Epub 2016 Jan 6.
4
High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.高双膦酸盐治疗率与系统性红斑狼疮患者非典型股骨骨折的患病率:日本单中心回顾性研究。
Rheumatol Int. 2019 Oct;39(10):1803-1810. doi: 10.1007/s00296-019-04407-4. Epub 2019 Aug 5.
5
Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort.韩国女性使用双膦酸盐后髋部和转子下或股骨干骨折:基于韩国全国样本队列研究
J Korean Med Sci. 2020 Jun 29;35(25):e193. doi: 10.3346/jkms.2020.35.e193.
6
T-Score Discordance of Bone Mineral Density in Patients with Atypical Femoral Fracture.非典型股骨骨折患者骨密度的T值不一致性
J Bone Joint Surg Am. 2017 Oct 4;99(19):1683-1688. doi: 10.2106/JBJS.16.01440.
7
Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case-Cohort Study With Blinded Radiographic Review.双膦酸盐的使用与非典型股骨骨折的风险:一项丹麦病例队列研究并进行盲法放射学评估。
J Clin Endocrinol Metab. 2024 Oct 15;109(11):e2141-e2150. doi: 10.1210/clinem/dgae023.
8
Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.韩国单中心 51 例股骨非典型性骨折患者的亚髁部与骨干部的关键性差异分析。
Arch Osteoporos. 2018 May 3;13(1):53. doi: 10.1007/s11657-018-0457-1.
9
Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry.双膦酸盐的使用与韩国转子下和骨干股骨骨折风险:来自国家索赔登记处的结果。
Calcif Tissue Int. 2019 Mar;104(3):313-319. doi: 10.1007/s00223-018-0493-2. Epub 2018 Nov 16.
10
Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.一家大型创伤中心双膦酸盐相关非典型股骨骨折的发病率及医疗处理:一项回顾性观察研究
BMC Musculoskelet Disord. 2017 Jan 23;18(1):29. doi: 10.1186/s12891-017-1392-9.

引用本文的文献

1
Atypical Femur Fractures-An Analysis of 69 Patients from 15 Years.非典型股骨骨折——15年69例患者分析
J Clin Med. 2025 Apr 1;14(7):2404. doi: 10.3390/jcm14072404.
2
Effect of Severe Bowing in Bisphosphonate-Related Atypical Femoral Fracture.双膦酸盐相关非典型股骨骨折中严重成角的影响
Clin Orthop Surg. 2025 Apr;17(2):216-222. doi: 10.4055/cios24103. Epub 2025 Feb 18.
3
Weight-Based Bisphosphonate Administration for Multiple Myeloma Patients and the Risks of Skeletal Complications.基于体重的双膦酸盐给药方案用于多发性骨髓瘤患者及骨骼并发症风险

本文引用的文献

1
Hospital information systems: experience at the fully digitized Seoul National University Bundang Hospital.医院信息系统:在全数字化的首尔国立大学盆唐医院的经验。
J Thorac Dis. 2016 Aug;8(Suppl 8):S637-41. doi: 10.21037/jtd.2016.08.44.
2
Trends of Incidence, Mortality, and Future Projection of Spinal Fractures in Korea Using Nationwide Claims Data.利用全国索赔数据分析韩国脊柱骨折的发病率、死亡率趋势及未来预测
J Korean Med Sci. 2016 May;31(5):801-5. doi: 10.3346/jkms.2016.31.5.801. Epub 2016 Mar 25.
3
Current trends and future projections of hip fracture in South Korea using nationwide claims data.
J Clin Med. 2023 Feb 18;12(4):1637. doi: 10.3390/jcm12041637.
4
Asian Ethnicity and Femoral Geometry in Atypical Femur Fractures: Independent or Interdependent Risk Factors?亚洲种族与非典型股骨骨折中的股骨几何形态:独立还是相互依存的风险因素?
JBMR Plus. 2022 Feb 17;6(4):e10607. doi: 10.1002/jbm4.10607. eCollection 2022 Apr.
5
Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study.脆性骨折手术后双膦酸盐(阿仑膦酸钠)起始治疗的时机:一项基于人群的队列研究。
J Clin Med. 2021 Jun 8;10(12):2541. doi: 10.3390/jcm10122541.
6
Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort.韩国女性使用双膦酸盐后髋部和转子下或股骨干骨折:基于韩国全国样本队列研究
J Korean Med Sci. 2020 Jun 29;35(25):e193. doi: 10.3346/jkms.2020.35.e193.
7
Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.对非典型股骨骨折的流行病学、病理生理学和治疗的现有认识。
Curr Osteoporos Rep. 2018 Aug;16(4):519-529. doi: 10.1007/s11914-018-0464-6.
利用全国索赔数据对韩国髋部骨折的当前趋势和未来预测
Osteoporos Int. 2016 Aug;27(8):2603-9. doi: 10.1007/s00198-016-3576-9. Epub 2016 Apr 25.
4
Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea.立场声明:韩国双膦酸盐治疗骨质疏松症中的药物假期
J Bone Metab. 2015 Nov;22(4):167-74. doi: 10.11005/jbm.2015.22.4.167. Epub 2015 Nov 30.
5
Radiographic Changes and Fracture in Patients Having Received Bisphosphonate Therapy for ≥ 5 Years at a Single Institution.在单一机构接受双膦酸盐治疗≥5年的患者的影像学改变和骨折情况
Mil Med. 2015 Dec;180(12):1214-8. doi: 10.7205/MILMED-D-14-00736.
6
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.长期双膦酸盐治疗患者的骨质疏松管理:美国骨与矿物质研究学会特别工作组报告
J Bone Miner Res. 2016 Jan;31(1):16-35. doi: 10.1002/jbmr.2708.
7
Atypical fractures of the femur: effect of anterolateral bowing of the femur on fracture location.股骨非典型骨折:股骨前外侧弓形对骨折部位的影响。
Arch Orthop Trauma Surg. 2015 Nov;135(11):1485-90. doi: 10.1007/s00402-015-2297-4. Epub 2015 Aug 19.
8
Management of osteoporosis in South Korea.韩国的骨质疏松症管理。
Crit Rev Eukaryot Gene Expr. 2015;25(1):33-40. doi: 10.1615/critreveukaryotgeneexpr.2015012425.
9
Pathogenesis, management and prevention of atypical femoral fractures.非典型股骨骨折的发病机制、治疗与预防
J Bone Metab. 2015 Feb;22(1):1-8. doi: 10.11005/jbm.2015.22.1.1. Epub 2015 Feb 28.
10
Efficacy, effectiveness and side effects of medications used to prevent fractures.用于预防骨折的药物的疗效、有效性和副作用。
J Intern Med. 2015 Jun;277(6):690-706. doi: 10.1111/joim.12339.